Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Metformin on Nicotine Withdrawal Syndrome Reduction and Nicotine Abstinence Increase, Double-Blind Placebo-Controlled, 12-Month Follow-Up
TCTR20190221004Phase 3Completed
- Sponsor
- N/A
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in nicotine dependence, sponsored by N/A. Started Feb 2015; status: completed.
02
Drugs
metformin
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on TCTR20190221004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190221004.